scispace - formally typeset
D

Dalmo Correia

Researcher at National Council for Scientific and Technological Development

Publications -  89
Citations -  1297

Dalmo Correia is an academic researcher from National Council for Scientific and Technological Development. The author has contributed to research in topics: Chagas disease & Medicine. The author has an hindex of 17, co-authored 82 publications receiving 1102 citations.

Papers
More filters
Journal ArticleDOI

2 nd Brazilian Consensus on Chagas Disease, 2015.

TL;DR: The evidence is presented that resulted in the Brazilian Consensus on Chagas Disease, which was to review and standardize strategies for diagnosis, treatment, prevention, and control of the disease in the country, based on the available scientific evidence.
Journal ArticleDOI

Problems and perspectives for Chagas disease control: in search of a realistic analysis

TL;DR: Consolidation of the victories against Chagas disease is attainable but depends on political will and continual attention from the most consequential protagonists in this struggle, especially the Latin American scientific community.
Journal ArticleDOI

Co-infection Trypanosoma cruzi/HIV: systematic review (1980 - 2010)

TL;DR: The lower survival rate was related to the reactivation of the Chagas disease and the natural complications of both diseases and the role of the antiretroviral treatment cannot yet be defined by the knowledge currently existent.
Journal ArticleDOI

Power spectral analysis of heart rate variability in HIV-infected and AIDS patients.

TL;DR: This work has shown that autonomic dysfunction has been detected in the early phase of HIV infection as well as in AIDS patients with advanced cardiomyopathy, and the risks for cardiovascular disease are multifactorial.
Journal ArticleDOI

Estudo comparativo entre antlmoniato de meglumina, isotianato de pentamidina e sulfato de aminosidine, no tratamento de lesões cutâneas primárias causadas por Leishmania (viannia) braziliensis

TL;DR: A field study was conducted on randomized treatment of patients with primary cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis in Cone de Pedra, BA, from October 1992 up to January 1993, and fifteen patients, except for one in Group 3, were cured.